STOCK TITAN

Vanguard realignment leads to 0 BDX holdings (Becton Dickinson & Co)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Becton Dickinson & Co Schedule 13G/A (Amendment No. 14) reports that The Vanguard Group disaggregated certain subsidiaries following an internal realignment and now reports 0 shares beneficially owned of the company's common stock, representing 0% of the class. The amendment explains the change is in accordance with SEC Release No. 34-39538 and reflects separate reporting by subsidiaries effective after the internal reorganization.

Positive

  • None.

Negative

  • None.

Insights

Vanguard's amendment reflects reporting realignment, not a market trade.

The filing states that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries now report separately under SEC Release No. 34-39538. The Schedule 13G/A shows Amount beneficially owned: 0 and Percent of class: 0%.

Cash‑flow treatment and trading activity are not described in the excerpt; subsequent filings from the reporting entities may disclose any holdings or transactions.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does The Vanguard Group report for BDX in this Schedule 13G/A?

The filing states The Vanguard Group reports 0 shares beneficially owned of Becton Dickinson common stock, equal to 0% of the class. It attributes the change to an internal realignment and separate subsidiary reporting.

Why does Vanguard report zero ownership for Becton Dickinson (BDX)?

Vanguard explains an internal realignment on January 12, 2026 led certain subsidiaries to report holdings separately under SEC Release No. 34-39538. As a result, The Vanguard Group reports 0 shares in this amendment.

Does the amendment show any voting or dispositive power by Vanguard over BDX shares?

The Schedule 13G/A lists sole voting power, shared voting power, sole dispositive power, and shared dispositive power all as 0. No voting or disposition powers are claimed here.

Does this filing indicate Vanguard sold BDX shares?

The amendment attributes the reporting change to internal reorganization and separate subsidiary reporting per SEC Release No. 34-39538; it does not state a sale or other transaction occurred in this excerpt.

Who signed the Schedule 13G/A amendment for Vanguard?

The form is signed by Ashley Grim, titled Head of Global Fund Administration, with a signature date of 03/26/2026, certifying the disclosure on behalf of The Vanguard Group.
Becton Dickinson & Co

NYSE:BDX

View BDX Stock Overview

BDX Rankings

BDX Latest News

BDX Latest SEC Filings

BDX Stock Data

44.77B
283.55M
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States
FRANKLIN LAKES